Sort
172,184 grants matching “inflammation”
Complement in Cell Proliferation and Injury-Therapeutic Interventions
$1,488,120John D Lambris · University Of Pennsylvania · P01 · FY2011 · AI
Xenobiotics and Allergic Inflammation
$1,487,792University Of California Los Angeles · P01 · FY2004 · AI
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma
$1,487,531Raymond T Chung · Massachusetts General Hospital · R01 · FY2025 · CA
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
$1,487,129Christine Cheng · University Of California, San Diego · U01 · FY2024 · DA
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
$1,486,653Leslee J Shaw · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation
$1,486,396James Versalovic · Baylor College Of Medicine · UH3 · FY2010 · DK
Pathophysiology of Ischemia-Reperfusion Injury
$1,486,250Louisiana State Univ Hsc Shreveport · P01 · FY2003 · DK
Pathophysiology of Ischemia-Reperfusion Injury
$1,486,250Louisiana State Univ Hsc Shreveport · P01 · FY2004 · DK
Pathophysiology of Ischemia-Reperfusion Injury
$1,486,250Louisiana State Univ Hsc Shreveport · P01 · FY2002 · DK
Pathophysiology of Ischemia-Reperfusion Injury
$1,486,250Louisiana State Univ Hsc Shreveport · P01 · FY2005 · DK
Helicobacter pylori Pathogenesis Studies
$1,486,035William Coleman · National Institute On Minority Health And Health Disparities · ZIA · FY2012 · MD
INTESTINAL IMMUNE SYSTEM IN HOST-ENVIRONMENT INTERACTION
$1,485,974Martin Frederick Kagnoff · University Of California, San Diego · P01 · FY2012 · DK
Development of Pathology-activated Drugs for Treatment of Neuropathic Pain
$1,485,925Peter M Grace · University Of Tx Md Anderson Can Ctr · UH3 · FY2024 · NS
Clinical and Molecular Epidemiology of High Risk Coronary Plaque
$1,485,906Svati H. Shah · Duke University · R01 · FY2019 · HL
Functions Of The NF-kappaB Family Of Proteins And Their Regulators
$1,485,842Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer
$1,485,601Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2023 · CA
Pharmacogenomics of Anti-platelet Agents for CVD Prevent
$1,485,240Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2006 · GM
Preclinical Development of an Anti-Mucus Drug
$1,485,085Michael Jay Holtzman · Washington University · UH2 · FY2015 · HL
Lung Damage from P. carinii: pathogenesis and prevention
$1,485,065University Of Rochester · P01 · FY2004 · HL
Developing a PET tracer targeting myeloperoxidase activity for neurodegenerative diseases
$1,484,822John W Chen · Massachusetts General Hospital · RF1 · FY2022 · AG
Novel antioxidant therapeutics for sulfur mustard toxicity (U54)
$1,484,634Carl W White · National Jewish Health · U54 · FY2007 · ES
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.
$1,484,514Stella Margaret Davies · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Genetics Core
$1,484,262Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2015 · AI
Brain-enriched microRNAs detectable in plasma as biomarkers of Alzheimer's Disease
$1,484,214Samuil R Umansky · Diamir, Llc · R44 · FY2021 · AG
Effects of Periodontal Therapy on Preterm Birth
$1,483,847University Of Minnesota Twin Cities · U01 · FY2004 · DE